Integrated Laboratory Systems, Inc. (ILS)
Integrated Laboratory Systems (ILS), part of Inotiv, Inc. (NASDAQ: NOTV), is a US-based discovery and development CRO providing nonclinical drug discovery, safety assessment, bioanalytical, and research model services to pharmaceutical, biotechnology, government, and academic clients.
- Company typePublic
- Founded1985
- HeadquartersMorrisville, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Integrated Laboratory Systems, Inc. (ILS) does
Integrated Laboratory Systems, Inc. (ILS) operates as a discovery and development contract research organization (CRO) under the Inotiv brand, providing nonclinical drug discovery and analytical services spanning disease pharmacology, drug metabolism and pharmacokinetics (DMPK), bioanalysis, histology, pathology, toxicology, and safety assessment. The platform pairs GLP-compliant scientific services with proprietary assets including AI-driven digital pathology for whole slide imaging, mass spectrometry-based antibody drug conjugate (ADC) assays developed against 27 targets, and the Eusoft Labs laboratory information management system (LIMS) and LabTracks research model tracking software. Founded in 1985 and headquartered in Morrisville, North Carolina, ILS is part of the publicly traded parent entity Inotiv, Inc. (NASDAQ: NOTV), previously known as Cumberland, and serves pharmaceutical and biotechnology companies as the primary customer segment with government agencies and academic research institutions as secondary segments across ten therapeutic areas. Revenue derives from professional services contracts for nonclinical studies (project-based to multi-year programs) and from product sales including research models and genetically engineered models (GEMS), Teklad-branded laboratory animal diets and bedding, and consumables, distributed through a B2B enterprise sales motion supported by scientific thought-leadership marketing via webinars, conferences, and technical publications. The most recent disclosed quarter (Q1 fiscal 2026) generated $120.9 million in revenue, up 0.8% year-over-year, and the company secured $65 million in new money financing in June 2026 following a cybersecurity incident disclosed in February 2026.
Integrated Laboratory Systems, Inc. (ILS) firmographics
Firmographics- Name
- Integrated Laboratory Systems, Inc. (ILS)
- Legal name
- Inotiv, Inc.
- Website
- https://ils-inc.com
- Company type
- Public
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Integrated Laboratory Systems (ILS), part of Inotiv, Inc. (NASDAQ: NOTV), is a US-based discovery and development CRO providing nonclinical drug discovery, safety assessment, bioanalytical, and research model services to pharmaceutical, biotechnology, government, and academic clients.
- Ownership category
- akta.pro rank
Integrated Laboratory Systems, Inc. (ILS) industry classification
Industry- Product category
- Preclinical Contract Research Services (CRO)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
- akta.pro secondary industries
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), DMPK / ADME & Bioanalysis (HLAGAFAC), Bioanalytical & PK/PD Sample Analysis (Trial Support) (HLAGAEAG), In Vivo Pharmacology (Efficacy/PD Models) (HLAGAFAA)
Keywords
Where Integrated Laboratory Systems, Inc. (ILS) is headquartered
LocationHeadquarters
- HQ city
- Morrisville
- HQ country
- United States
- HQ region
- North America
Markets served
Integrated Laboratory Systems, Inc. (ILS) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Contract Research Services: Nonclinical and analytical services spanning drug discovery through clinical development, including toxicology studies, DMPK, pathology, and bioanalysis. Services are project-based with study-specific contracts typically ranging from short-term studies to multi-year programs
- Research Models and Related Services: Sale of research models (laboratory animals) and associated services including genetically engineered models (GEMS), contract breeding, surgical services, genetic testing, and biospecimen services. Also includes Teklad™ laboratory animal diets, bedding, and enrichment products
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Research Models - Standard natural ingredient diets |
| Unit Pricing | Pay-as-you-go | Custom Research Diets |
| Other | Multi-year contract | Contract Research Services |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Integrated Laboratory Systems, Inc. (ILS) product offering
Product offeringCore offering
ILS provides nonclinical contract research organization (CRO) services and research products spanning the drug discovery and development lifecycle, including discovery and translational sciences (disease pharmacology, DMPK, bioanalysis, toxicology, histology), GLP-compliant safety assessment (toxicology, genetic toxicology, DART, carcinogenicity, bioanalysis), research models with genetically engineered models and support services, Teklad laboratory animal diets and enrichment products, monoclonal antibody production, and proprietary software (Eusoft Labs LIMS, LabTracks) plus AI-driven digital pathology and 27-target mass spectrometry ADC assays.
Product overview
Inotiv is a Discovery and Development Contract Research Organization (CRO) offering a unified platform of nonclinical and analytical services spanning discovery through clinical development. The portfolio comprises four core pillars: Discovery and Translational Sciences (disease pharmacology, DMPK, bioanalysis, toxicology, histology), Safety Assessment (GLP toxicology, pathology, bioanalysis, medical device testing), Research Models and Services (research models, GEMS, breeding, surgical services), and Teklad Laboratory Animal Diets (specialty diets, bedding, enrichment). Supporting software products include Eusoft Labs (LIMS) and LabTracks for data management. The company also offers specialized services in digital pathology with AI-driven image analysis and monoclonal antibody production.
Differentiator
Problem solved
Functional benefit
Brands
- Teklad: Laboratory animal diets, bedding, and enrichment products
- Eusoft Labs
- LabTracks
Products and services
- Discovery and Translational Sciences Comprehensive nonclinical services including disease pharmacology (in vitro and in vivo), DMPK, discovery bioanalysis and biomarkers, cell and molecular biology, predictive and computational toxicology, toxicogenomics, targeted proteomics, histology and pathology, and consultative drug discovery programs for pharmaceutical and biotechnology sponsors.
- Safety Assessment Full-service GLP-compliant safety assessment including exploratory, genetic, safety pharmacology, DART, and carcinogenicity toxicology; pathology; bioanalysis for large and small molecules; impurities assessment; archive services; medical device testing and surgical support; SEND; cell and gene therapy; and chemical services support.
- Research Models and Services Comprehensive range of research models paired with support services including genetically engineered models (GEMS), contract breeding, surgical services, genetic testing, biospecimen services, custom antibody production, and full-spectrum health monitoring for pharma, biotech, government, and academic researchers.
- Teklad Laboratory Animal Diets, Bedding and Enrichment Specialty laboratory animal diets (standard natural ingredient diets, custom research diets, medicated diets), contact bedding, custom-cut paper cage liners, and WelfarePlus+ enrichment products for research animal facilities.
- Monoclonal Antibody Production Quality custom monoclonal antibody production services for small-scale and large-scale production to meet research and development needs of pharmaceutical and academic customers.
- Eusoft Labs (LIMS) Proprietary Laboratory Information Management System (LIMS) for research model and laboratory data tracking and management, available to research facilities managing animal colonies and study data.
- LabTracks Proprietary tracking and monitoring system for research models and associated laboratory operations, providing visibility into animal colony management and study workflows.
- Antibody Drug Conjugate (ADC) Mass Spectrometry Assays Proprietary mass spectrometry assays to quantify ADC target proteins in any sample type, including FFPE tissue, without antibodies; currently validated against 27 ADC targets for oncology and other therapeutic applications.
Companies that use Integrated Laboratory Systems, Inc. (ILS)
Customer profileSegments3 records
Ideal customer profiles2 records
Integrated Laboratory Systems, Inc. (ILS) technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Integrated Laboratory Systems, Inc. (ILS) partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Integrated Laboratory Systems, Inc. (ILS) competitors and assessment
Company assessmentDirect peers
- SGS SA: Provides preclinical and clinical bioanalytical, safety, and central lab services globally, overlapping with Inotiv's GLP bioanalysis and safety assessment offerings.
- WuXi AppTec: Global CRO/CDMO with extensive preclinical toxicology, DMPK, bioanalytical, and research model services that compete head-to-head for outsourced nonclinical work.
- Taconic Biosciences: Leading supplier of genetically engineered rodent models and associated research services, competing directly with Inotiv's GEMS and research model business.
- Pharmaron: Integrated CRO/CDMO with nonclinical safety assessment, DMPK, bioanalytical, and in vivo pharmacology capabilities that compete for outsourced preclinical programs.
- Eurofins Scientific: Major bioanalytical and central laboratory services provider with deep pharma testing overlap, particularly in regulated GLP bioanalysis and biomarker assays.
- Charles River Laboratories: Largest pure-play preclinical CRO offering research models, discovery, safety assessment, DMPK, and bioanalytical services that directly overlap with Inotiv's core offerings across the same biopharma customer base.
Broad incumbents
- IQVIA: Diversified life sciences services giant with preclinical/early-phase capabilities complemented by extensive clinical, real-world evidence, and technology offerings serving similar pharma/biotech buyers.
- ICON plc: Large CRO with growing nonclinical and bioanalytical footprint (post-PRA Health and other deals), competing for integrated drug development programs with similar sponsors.
- Labcorp (Drug Development / Fortrea): Global clinical and nonclinical CRO providing overlapping preclinical safety, bioanalytical, and central lab services alongside a much larger diagnostics and clinical trial portfolio.
Emerging players
- Crown Bioscience (JSR Life Sciences): Specialty preclinical CRO focused on oncology and immuno-oncology translational models, overlapping with Inotiv's in vivo pharmacology and ADC assay services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Integrated Laboratory Systems, Inc. (ILS) social profiles
Digital presenceIntegrated Laboratory Systems, Inc. (ILS) compliance and trust
Trust signalCompliance1 record
Integrated Laboratory Systems, Inc. (ILS) financial estimates
Financial estimateRevenue estimate
Valuation estimate
Integrated Laboratory Systems, Inc. (ILS) leadership team
Management profileNumber of profiles
Integrated Laboratory Systems, Inc. (ILS) funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Integrated Laboratory Systems, Inc. (ILS) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Integrated Laboratory Systems, Inc. (ILS)
What does Integrated Laboratory Systems, Inc. (ILS) do?
ILS provides nonclinical contract research organization (CRO) services and research products spanning the drug discovery and development lifecycle, including discovery and translational sciences (disease pharmacology, DMPK, bioanalysis, toxicology, histology), GLP-compliant safety assessment (toxicology, genetic toxicology, DART, carcinogenicity, bioanalysis), research models with genetically engineered models and support services, Teklad laboratory animal diets and enrichment products, monoclonal antibody production, and proprietary software (Eusoft Labs LIMS, LabTracks) plus AI-driven digital pathology and 27-target mass spectrometry ADC assays.
Is Integrated Laboratory Systems, Inc. (ILS) a public or private company?
Integrated Laboratory Systems, Inc. (ILS) is a public company. It is classified as unknown and is currently operating.
When was Integrated Laboratory Systems, Inc. (ILS) founded?
Integrated Laboratory Systems, Inc. (ILS) was founded in 1985. It employs 101 to 250 people.
Where is Integrated Laboratory Systems, Inc. (ILS) based?
Integrated Laboratory Systems, Inc. (ILS) is headquartered in Morrisville, United States, in the North America region.
How does Integrated Laboratory Systems, Inc. (ILS) make money?
Two revenue lines are on record. Contract Research Services are the primary driver. The others are research Models and Related Services.
Who are Integrated Laboratory Systems, Inc. (ILS)'s main competitors?
Direct peers on record are SGS SA, WuXi AppTec, Taconic Biosciences, Pharmaron, Eurofins Scientific and Charles River Laboratories. Broad incumbents are IQVIA, ICON plc and Labcorp (Drug Development / Fortrea). Crown Bioscience (JSR Life Sciences) is listed as an emerging player.
Does Integrated Laboratory Systems, Inc. (ILS) have an API?
No public API is recorded for Integrated Laboratory Systems, Inc. (ILS).
What industry is Integrated Laboratory Systems, Inc. (ILS) in?
Integrated Laboratory Systems, Inc. (ILS)'s product category is Preclinical Contract Research Services (CRO). Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 541714 and its SIC code is 8731.